Supplemental material, sj-docx-1-cat-10.1177_10760296231213073 for Treatment Patterns and Healthcare Resource Utilization of Patients With Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Claims Data Analysis by Denise Clayton, Jason Shafrin, Glorian Yen, Soyon Lee, Lincy Geevarghese, Yulin Shi, Luyang He, Ying Shen and Anem Waheed in Clinical and Applied Thrombosis/Hemostasis</p
Supplemental material, sj-docx-1-cat-10.1177_10760296231203663 for Differential Diagnostic Value of ...
Supplemental material, sj-docx-2-tah-10.1177_20406207231155028 for Efficacy and safety of venetoclax...
Supplemental material, sj-docx-1-dhj-10.1177_20552076221149528 for A new machine learning algorithm ...
Supplemental material, sj-docx-1-cat-10.1177_10760296241231944 for Investigating the Impact on Long-...
Supplemental material, sj-docx-1-cat-10.1177_10760296221121287 for Clinical Significance and Dynamic...
Supplemental material, sj-docx-1-jic-10.1177_08850666221126661 for Impact on Blood Product Utilizati...
Supplemental material, sj-docx-1-aop-10.1177_10600280221129348 for Direct Oral Anticoagulants Versus...
Contains fulltext : 136926.pdf (publisher's version ) (Open Access)Paroxysmal noct...
Supplemental material, sj-docx-2-aop-10.1177_10600280221129348 for Direct Oral Anticoagulants Versus...
Supplemental material, sj-zip-1-cat-10.1177_10760296221121286 for Association of Red Blood Cell Dist...
Supplemental material, sj-docx-1-taw-10.1177_20420986221146418 for Patient-centered pharmacovigilanc...
Supplemental material, sj-docx-1-cat-10.1177_10760296221151164 for Derivation and External Validatio...
Supplemental material, sj-docx-1-hpx-10.1177_00185787231196428 for Impact of Iron Supplementation on...
Supplemental material, sj-docx-1-tah-10.1177_20406207231155028 for Efficacy and safety of venetoclax...
Supplemental material, sj-docx-6-tah-10.1177_20406207231155028 for Efficacy and safety of venetoclax...
Supplemental material, sj-docx-1-cat-10.1177_10760296231203663 for Differential Diagnostic Value of ...
Supplemental material, sj-docx-2-tah-10.1177_20406207231155028 for Efficacy and safety of venetoclax...
Supplemental material, sj-docx-1-dhj-10.1177_20552076221149528 for A new machine learning algorithm ...
Supplemental material, sj-docx-1-cat-10.1177_10760296241231944 for Investigating the Impact on Long-...
Supplemental material, sj-docx-1-cat-10.1177_10760296221121287 for Clinical Significance and Dynamic...
Supplemental material, sj-docx-1-jic-10.1177_08850666221126661 for Impact on Blood Product Utilizati...
Supplemental material, sj-docx-1-aop-10.1177_10600280221129348 for Direct Oral Anticoagulants Versus...
Contains fulltext : 136926.pdf (publisher's version ) (Open Access)Paroxysmal noct...
Supplemental material, sj-docx-2-aop-10.1177_10600280221129348 for Direct Oral Anticoagulants Versus...
Supplemental material, sj-zip-1-cat-10.1177_10760296221121286 for Association of Red Blood Cell Dist...
Supplemental material, sj-docx-1-taw-10.1177_20420986221146418 for Patient-centered pharmacovigilanc...
Supplemental material, sj-docx-1-cat-10.1177_10760296221151164 for Derivation and External Validatio...
Supplemental material, sj-docx-1-hpx-10.1177_00185787231196428 for Impact of Iron Supplementation on...
Supplemental material, sj-docx-1-tah-10.1177_20406207231155028 for Efficacy and safety of venetoclax...
Supplemental material, sj-docx-6-tah-10.1177_20406207231155028 for Efficacy and safety of venetoclax...
Supplemental material, sj-docx-1-cat-10.1177_10760296231203663 for Differential Diagnostic Value of ...
Supplemental material, sj-docx-2-tah-10.1177_20406207231155028 for Efficacy and safety of venetoclax...
Supplemental material, sj-docx-1-dhj-10.1177_20552076221149528 for A new machine learning algorithm ...